← All stocks

Elicio Therapeutics, Inc.

ELTX Net buying
CIK 0001601485 #4465 in the set updated 22 Sep 2026
Bought (120 mo)
$8.22M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.74M
$0.00 on a plan · $6.49M straight out of an exercise
Sold at will
$1.25M
28 of 30 sales
Net
+$471.53K
+$6.97M against sales at will

By person

15 insiders · 51 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chudnovsky Yekaterina
Director
$7.05M (1)
+$7.05M
5,416,212
$31.47M
+670.8%
GANZI VICTOR F
Director
$3.95M (1) scheduled
−$3.95M
731,978
$4.25M
+35.0%
Venkatesan Jay
Director
$1.15M (9)
$2.55M (1) scheduled
−$1.40M
179,581
$1.04M
Goldberg Itzhak
Director
$1.15M (6)
−$1.15M
1,687,986
$9.81M
−19.8%
Rhodes Jennifer J
See Remarks
$62.43K (12)
−$62.43K
30,399
$176.62K
−14.8%
Neylan John F.
See Remarks
$40.43K (10)
−$40.43K
35,136
$204.14K
−9.7%
Nissenson Allen
Director
$10.93K (2)
+$10.93K
9,383
$54.52K
CURHAN GREGORY S
See Remarks
$9.48K (1)
+$9.48K
4,000
$23.24K
EISA-ABC LLC entity
10% owner
2,740,978
$15.93M
−25.0%
Connelly Robert
CEO, President and Director
120,570
$700.51K
+156.7%
OMENN GILBERT S
Director
80,326
$466.69K
+330.3%
Haqq Christopher
See Remarks
57,381
$333.38K
+79.4%
Shah Preetam
See Remarks
24,000
$139.44K
DeMuth Peter
Chief Scientific Officer
21,543
$125.16K
WILSON KAREN J
Director
18,718
$108.75K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 10,791,326 to 26,281,882 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
DeMuth Peter
9 Dec 2025
Chief Scientific Officer
Exercised, kept
362
$4.41
$1.60K
Chudnovsky Yekaterina
5 Mar 2025
Director
Exercised, kept indirect
3,500,573
$5.81
$20.34M
DeMuth Peter
16 Dec 2024
Chief Scientific Officer
Exercised, kept
381
$4.41
$1.68K
Venkatesan Jay
26 Nov 2024
Director
Exercised, kept
50,000
$0.01
$500.00
Chudnovsky Yekaterina
22 Dec 2023
Director
Buy indirect
1,213,000
$5.81
$7.05M
Venkatesan Jay
25 May 2022
See Remarks
Buy
11,313
$1.25
$14.10K
Venkatesan Jay
24 May 2022
See Remarks
Buy
32,200
$1.24
$39.93K
Nissenson Allen
20 May 2022
Director
Buy
2,037
$1.18
$2.40K
Venkatesan Jay
20 May 2022
See Remarks
Buy
50,000
$1.23
$61.50K
Nissenson Allen
19 May 2022
Director
Buy
7,346
$1.16
$8.52K
Venkatesan Jay
28 Dec 2021
See Remarks
Buy
210,337
$2.66
$559.85K
Venkatesan Jay
27 Dec 2021
See Remarks
Buy
66,907
$2.55
$170.52K
Neylan John F.
20 Dec 2021
See Remarks
Sell
358
$2.62
$938.00
Venkatesan Jay
20 Dec 2021
See Remarks
Buy
3,527
$2.54
$8.98K
Venkatesan Jay
17 Dec 2021
See Remarks
Buy
13,742
$2.54
$34.96K
Venkatesan Jay
16 Dec 2021
See Remarks
Buy
27,883
$2.55
$70.99K
CURHAN GREGORY S
15 Dec 2021
See Remarks
Buy
4,000
$2.37
$9.48K
Venkatesan Jay
15 Dec 2021
See Remarks
Buy
77,604
$2.41
$186.96K
Rhodes Jennifer J
14 Dec 2021
See Remarks
Sell
451
$2.42
$1.09K
Goldberg Itzhak
6 Dec 2021
See Remarks
Sell
32,118
$3.35
$107.72K
Goldberg Itzhak
3 Dec 2021
See Remarks
Sell
40,215
$3.39
$136.22K
Goldberg Itzhak
2 Dec 2021
See Remarks
Sell
38,800
$3.51
$136.33K
Goldberg Itzhak
1 Dec 2021
See Remarks
Sell
38,867
$3.54
$137.67K
Neylan John F.
18 Nov 2021
See Remarks
Sell
374
$4.13
$1.54K
Goldberg Itzhak
16 Nov 2021
See Remarks
Sell
38,495
$4.26
$163.81K
Rhodes Jennifer J
15 Nov 2021
See Remarks
Sell
433
$4.40
$1.91K
Goldberg Itzhak
15 Nov 2021
See Remarks
Sell
111,505
$4.17
$465.24K
Neylan John F.
18 Oct 2021
See Remarks
Sell
373
$8.62
$3.22K
Rhodes Jennifer J
14 Oct 2021
See Remarks
Sell
430
$8.65
$3.72K
Neylan John F.
20 Sep 2021
See Remarks
Sell
376
$10.07
$3.79K
Rhodes Jennifer J
14 Sep 2021
See Remarks
Sell
430
$10.64
$4.58K
Neylan John F.
18 Aug 2021
See Remarks
Sell
381
$9.03
$3.44K
Rhodes Jennifer J
16 Aug 2021
See Remarks
Sell
445
$10.68
$4.75K
Neylan John F.
21 Jul 2021
See Remarks
Sell
365
$10.98
$4.01K
Rhodes Jennifer J
21 Jul 2021
See Remarks
Sell
432
$10.94
$4.73K
Rhodes Jennifer J
14 Jul 2021
See Remarks
Sell
431
$11.01
$4.75K
Neylan John F.
18 Jun 2021
See Remarks
Sell
366
$13.20
$4.83K
Rhodes Jennifer J
14 Jun 2021
See Remarks
Sell
427
$13.27
$5.67K
Neylan John F.
18 May 2021
See Remarks
Sell
363
$13.91
$5.05K
Rhodes Jennifer J
14 May 2021
See Remarks
Sell
440
$13.92
$6.12K
Neylan John F.
19 Apr 2021
See Remarks
Sell
381
$13.55
$5.16K
Rhodes Jennifer J
15 Apr 2021
See Remarks
Sell
399
$15.01
$5.99K
Neylan John F.
17 Mar 2021
See Remarks
Sell
442
$19.13
$8.46K
Rhodes Jennifer J
13 Mar 2021
See Remarks
Sell
499
$20.45
$10.20K
Rhodes Jennifer J
13 Feb 2021
See Remarks
Sell
457
$19.54
$8.93K
GANZI VICTOR F
9 Feb 2021
Director
Sold after exercise
246,720
$16.00
$3.95M
OMENN GILBERT S
9 Feb 2021
Director
Exercised, kept indirect
14,783
$11.57
$171.04K
OMENN GILBERT S
9 Feb 2021
Director
Exercised, kept indirect
23,391
$11.57
$270.63K
OMENN GILBERT S
9 Feb 2021
Director
Exercised, kept indirect
23,483
$11.57
$271.70K
WILSON KAREN J
9 Feb 2021
Director
Exercised, kept
18,718
$11.57
$216.57K
Venkatesan Jay
9 Feb 2021
See Remarks
Sold after exercise
159,177
$16.00
$2.55M

What was left out

Form 4 filings counted 114
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 5,719,013
Sales filed before the plan box existed 28
History held since 8 Feb 2021